Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1983 Aug;50(2):170–175. doi: 10.1136/hrt.50.2.170

Non-invasive measuring of the circulatory effect of afterload reduction in order to monitor the pharmacodynamic effect of drugs in normal volunteers.

J Buch, S Waldorff, P B Hansen, O O Rasmussen
PMCID: PMC481391  PMID: 6882604

Abstract

In order to measure the effect of a decrease in afterload on systolic time intervals, left ventricular end-systolic diameter, and left ventricular wall stress, eight healthy young persons underwent a randomised placebo controlled trial of terbutaline before and during atenolol treatment. Pre-ejection period index, left ventricular end-systolic diameter, and wall stress all decreased after terbutaline, the decrease being clearly dose dependent. This was identical before and during atenolol administration. Consequently the observed changes were induced by beta-2 elicited vasodilatation, possibly combined with some decrease of parasympathetic tone. A close correlation between changes in pre-ejection period index (PEPI) and changes in left ventricular end-systolic diameter (LVESD) and wall stress was shown both before and during atenolol treatment. When using non-invasive methods in the evaluation of changes in contractility, it is important to correct for changes in preload and afterload. For normal subjects it is suggested that the relation between delta PEPI and delta LVESD as a percentage of the mean values should be used for evaluation of afterload changes. A method is suggested for estimating changes in pre-ejection period index induced by changes in left ventricular end-systolic diameter or wall stress.

Full text

PDF
170

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed S. S., Levinson G. E., Schwartz C. J., Ettinger P. O. Systolic time intervals as measures of the contractile state of the left ventricular myocardium in man. Circulation. 1972 Sep;46(3):559–571. doi: 10.1161/01.cir.46.3.559. [DOI] [PubMed] [Google Scholar]
  2. Arner B., Bertler A., Karlefors T., Westling H. Circulatory effects of orciprenaline, adrenaline and a new sympathomimetic beta-receptor-stimulating agent, terbutaline, in normal human subjects. Acta Med Scand Suppl. 1970;512:25–32. doi: 10.1111/j.0954-6820.1970.tb05286.x. [DOI] [PubMed] [Google Scholar]
  3. Buch J., Egeblad H., Hansen P. B., Kjaergård H., Waldorff S., Steiness E. Correlation between changes in systolic time intervals and left ventricular end-diastolic diameter after preload reduction. Non-invasive monitoring of pharmacological intervention. Br Heart J. 1980 Dec;44(6):668–671. doi: 10.1136/hrt.44.6.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bugge-Asperheim B., Lekven J., Kiil F. Effect of saline infusion on stroke volume and end-systolic volume at various levels of adrenergic activity in dogs. Scand J Clin Lab Invest. 1972 Feb;29(1):15–24. doi: 10.3109/00365517209081050. [DOI] [PubMed] [Google Scholar]
  5. Carlström S., Westling H. Metabolic, circulatory and respiratory effects of a new sympathomimetic beta-receptor-stimulating agent, terbutaline, compared with those of orciprenaline. Acta Med Scand Suppl. 1970;512:33–40. doi: 10.1111/j.0954-6820.1970.tb05287.x. [DOI] [PubMed] [Google Scholar]
  6. Danilo P., Jr, Rosen T. S. Effects of terbutaline on cardiac automaticity and contractility. J Clin Pharmacol. 1982 May-Jun;22(5-6):223–230. doi: 10.1002/j.1552-4604.1982.tb02665.x. [DOI] [PubMed] [Google Scholar]
  7. Dodek A., Burg J. R., Kloster F. R. Systolic time intervals in chronic hypertension: Alterations and response to treatment. Chest. 1975 Jul;68(1):51–55. doi: 10.1378/chest.68.1.51. [DOI] [PubMed] [Google Scholar]
  8. Garrard C. L., Jr, Weissler A. M., Dodge H. T. The relationship of alterations in systolic time intervals to ejection fraction in patients with cardiac disease. Circulation. 1970 Sep;42(3):455–462. doi: 10.1161/01.cir.42.3.455. [DOI] [PubMed] [Google Scholar]
  9. Hörnblad Y., Ripe E., Leideman T. Hexoprenaline and terbutaline administered by inhalation. A comparison between two beta2-adrenoreceptor agonists with respect to effect on bronchial obstruction, heart rate, blood pressure and muscle tremor. Scand J Respir Dis. 1978 Jun;59(3):160–166. [PubMed] [Google Scholar]
  10. Larsson S., Svedmyr N. Cumulative dose-response curves for early evaluation of bronchodilator drugs. Ann Allergy. 1978 Dec;41(6):348–351. [PubMed] [Google Scholar]
  11. Man in 't Veld A. J., Wenting G. J., Boomsma F., Verhoeven R. P., Schalekamp M. A. Sympathetic and parasympathetic components of reflex cardiostimulation during vasodilator treatment of hypertension. Br J Clin Pharmacol. 1980 Jun;9(6):547–551. doi: 10.1111/j.1365-2125.1980.tb01079.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Quinones M. A., Gaasch W. H., Cole J. S., Alexander J. K. Echocardiographic determination of left ventricular stress-velocity relations. Circulation. 1975 Apr;51(4):689–700. doi: 10.1161/01.cir.51.4.689. [DOI] [PubMed] [Google Scholar]
  13. Rankin L. S., Moos S., Grossman W. Alterations in preload and ejection phase indices of left ventricular performance,. Circulation. 1975 May;51(5):910–915. doi: 10.1161/01.cir.51.5.910. [DOI] [PubMed] [Google Scholar]
  14. Reichek N., Wilson J., St John Sutton M., Plappert T. A., Goldberg S., Hirshfeld J. W. Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation. 1982 Jan;65(1):99–108. doi: 10.1161/01.cir.65.1.99. [DOI] [PubMed] [Google Scholar]
  15. Sharma B., Goodwin J. F. Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle. Circulation. 1978 Sep;58(3 Pt 1):449–460. doi: 10.1161/01.cir.58.3.449. [DOI] [PubMed] [Google Scholar]
  16. Simonsson B. G., Stiksa J., Ström B. Double-blind trial with increasing doses of salbutamol and terbutaline aerosols in patients with reversible airways obstruction. Acta Med Scand. 1972 Nov;192(5):371–376. doi: 10.1111/j.0954-6820.1972.tb04832.x. [DOI] [PubMed] [Google Scholar]
  17. Slutsky R., Hooper W., Gerber K., Ashburn W., Curtis G., Karliner J. Left ventricular size and function after subcutaneous administration of terbutaline. Chest. 1981 May;79(5):501–505. doi: 10.1378/chest.79.5.501. [DOI] [PubMed] [Google Scholar]
  18. Talley R. C., Meyer J. F., McNay J. L. Evaluation of the pre-ejection period as an estimate of myocardial contractility in dogs. Am J Cardiol. 1971 Apr;27(4):384–391. doi: 10.1016/0002-9149(71)90435-8. [DOI] [PubMed] [Google Scholar]
  19. Tarazi R. C., Frohlich E. D., Dustan H. P. Left atrial abnormality and ventricular preejection period in hypertension. Dis Chest. 1969 Mar;55(3):214–218. doi: 10.1378/chest.55.3.214. [DOI] [PubMed] [Google Scholar]
  20. WALLACE A. G., MITCHELL J. H., SKINNER N. S., SARNOFF S. J. Duration of the phases of left ventricular systole. Circ Res. 1963 Jun;12:611–619. doi: 10.1161/01.res.12.6.611. [DOI] [PubMed] [Google Scholar]
  21. Weissler A. M., Harris W. S., Schoenfeld C. D. Systolic time intervals in heart failure in man. Circulation. 1968 Feb;37(2):149–159. doi: 10.1161/01.cir.37.2.149. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES